Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Balazs

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Cell Reports. Medicine|November 24, 2022
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen designBlake M Hauser, Jared Feldman, Maya Sangesland, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variantWilfredo F Garcia-Beltran, Kerri J St Denis, Angelique Hoelzemer, et al.
Molecular Therapy. Methods & Clinical Development|July 24, 2019
AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 RegionFiona T van den Berg, Nigel A Makoah, Stuart A Ali, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
AIDS Research and Human Retroviruses|December 17, 2015
Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop SummaryRamesh Akkina, Atef Allam, Alejandro B Balazs, et al.
Nature|March 29, 2021
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasmaSandile Cele, Inbal Gazy, Laurelle Jackson, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residentsDavid H Canaday, Lenore Carias, Oladayo A Oyebanji, et al.
Cell Reports. Medicine|November 24, 2022
Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen designBlake M Hauser, Jared Feldman, Maya Sangesland, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individualsVivek Naranbhai, Anusha Nathan, Clarety Kaseke, et al.
Aging Clinical and Experimental Research|October 15, 2021
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Oladayo A Oyebanji, Brigid Wilson, Debbie Keresztesy, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variantWilfredo F Garcia-Beltran, Kerri J St Denis, Angelique Hoelzemer, et al.
Molecular Therapy. Methods & Clinical Development|July 24, 2019
AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 RegionFiona T van den Berg, Nigel A Makoah, Stuart A Ali, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
AIDS Research and Human Retroviruses|December 17, 2015
Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop SummaryRamesh Akkina, Atef Allam, Alejandro B Balazs, et al.
Nature|March 29, 2021
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasmaSandile Cele, Inbal Gazy, Laurelle Jackson, et al.
Pageof 11